Ovsepian, S.V. ; O’Leary, V.B.*
Can arginase inhibitors be the answer to therapeutic challenges in Alzheimer's disease?
Neurotherapeutics 15, 1032-1035 (2018)
O’Leary, V.B.* ; O’Connell, M.* ; Antyborzec, I.* ; Ntziachristos, V. ; Oliver Dolly, J.* ; Ovsepian, S.V.
Alleviation of trigeminal nociception using p75 neurotrophin receptor targeted lentiviral interference therapy.
Neurotherapeutics 15, 489-499 (2018)
Antyborzec, I.* ; O'Leary, V.B. ; Dolly, J.O.* ; Ovsepian, S.V.
Low-affinity neurotrophin receptor p75 promotes the transduction of targeted lentiviral vectors to cholinergic neurons of rat basal forebrain.
Neurotherapeutics 13, 859-870 (2016)
Zach, N.* ; Ennist, D.L.* ; Taylor, A.A.* ; Alon, H.* ; Sherman, A.V.* ; Küffner, R. ; Walker, J.* ; Sinani, E.* ; Katsovskiy, I.* ; Cudkowicz, M.E.* ; Leitner, M.L.*
Being PRO-ACTive: What can a clinical trial database reveal about ALS?
Neurotherapeutics 12, 417-423 (2015)